Viewing Study NCT04162366


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2025-12-25 @ 2:11 PM
Study NCT ID: NCT04162366
Status: WITHDRAWN
Last Update Posted: 2022-11-23
First Post: 2019-11-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-01
Start Date Type: ESTIMATED
Primary Completion Date: 2021-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-07-15
Completion Date Type: ESTIMATED
First Submit Date: 2019-11-11
First Submit QC Date: None
Study First Post Date: 2019-11-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-11-22
Last Update Post Date: 2022-11-23
Last Update Post Date Type: ACTUAL